)
Visual
test
Lucid Diagnostics
Lucid Diagnostics (LUCD) investor relations material
Lucid Diagnostics Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary26 Mar, 2026
Executive summary
Q4 2025 EsoGuard test volume reached 3,664, a 29% sequential increase, generating $1.5 million in revenue and surpassing the target range.
Awarded a U.S. Department of Veterans Affairs contract for EsoGuard, expanding access to 170 VA medical centers serving approximately nine million veterans.
Positive real-world data from nearly 12,000 at-risk patients confirmed high technical success, safety, and rapid procedure times for EsoGuard and EsoCheck.
Significant progress in commercial payer engagement, including UnitedHealthcare and laboratory benefit managers (LBMs), with updated EGD guidelines supporting broader adoption.
Focus for 2026 includes converting demand into revenue, deepening VA relationships, expanding health system adoption, and advancing commercial and Medicare coverage.
Financial highlights
Q4 2025 revenue was $1.5 million, up from $1.2 million in Q4 2024; full-year revenue rose to $4.7 million from $4.3 million.
Cash and cash equivalents at year-end 2025 were $34.7 million, up from $22.4 million a year earlier.
Q4 2025 GAAP net loss attributable to common stockholders was $16.3 million, or $(0.12) per share; non-GAAP adjusted loss was $12.6 million, or $(0.10) per share.
Non-GAAP operating expenses rose to $48.7 million in 2025 from $44.3 million in 2024, mainly due to increased sales and market access staffing.
Senior secured convertible notes increased to $24.0 million from $18.6 million year-over-year.
Outlook and guidance
Anticipates imminent Medicare coverage, which would retroactively cover claims up to one year prior.
Expanded reimbursement and coverage pathways, including CMS and multi-payor coverage, are expected to support future growth.
Ongoing efforts to secure additional commercial payer and LBM coverage, with positive developments expected in coming quarters.
Implementation of EsoGuard in the VA healthcare system positions the company for broader adoption.
Focus for 2026 is on revenue growth, expanded coverage, and deepening relationships with VA and health systems.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Lucid Diagnostics
- Flexible $175M shelf and $25M ATM offering targets growth amid ongoing losses and dilution risk.LUCD
Registration filing26 Mar 2026 - All proposals, including director elections and share increases, were approved by shareholders.LUCDAGM 20243 Feb 2026
- Record test growth and robust clinical data set the stage for expanded coverage and revenue.LUCDCanaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026
- Record test volume and strong clinical data drive growth, but funding and reimbursement risks remain.LUCDQ2 20241 Feb 2026
- Innovative pre-cancer screening and reimbursement progress set the stage for strong growth.LUCDMaxim Group’s 2024 Healthcare Virtual Summit19 Jan 2026
- Q3 revenue up 20% to $1.2M, record test volumes, but losses and funding risks persist.LUCDQ3 202414 Jan 2026
- Record test volume, expanded coverage, and improved cash position drive growth outlook.LUCDQ4 202424 Dec 2025
- Offering up to $175M in securities, with ongoing losses and significant dilution risk.LUCDRegistration Filing16 Dec 2025
- Registration enables resale of 72.4M shares, with major dilution and financial risks disclosed.LUCDRegistration Filing16 Dec 2025
Next Lucid Diagnostics earnings date
Q1 202613 May, 2026
Lucid Diagnostics
Next Lucid Diagnostics earnings date
Q1 202613 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage